The application effects of Methyl-β-cyclodextrin in cancer drug delivery mainly manifest in the following aspects:
1.Enhancing drug solubility and stability: Many anticancer drugs have low water solubility due to their properties. Adding Methyl-β-cyclodextrin can form inclusion complexes, increasing drug solubility, thereby enhancing drug delivery efficiency.
2.Increasing uptake by tumor cells: Methyl-β-cyclodextrin can increase drug concentration on the cell membrane, enhancing the uptake of drugs by cancer cells and thus improving the therapeutic effect of the drugs.
3.Achieving targeted delivery: By combining with targeting ligands or modifications, Methyl-β-cyclodextrin can be designed for targeted delivery to cancer cells, reducing damage to normal cells and enhancing the therapeutic effect of drugs.
4.Regulating drug release rate: Methyl-β-cyclodextrin can control the release rate of drugs to some extent, achieving sustained or controlled release effects and prolonging the drug's duration of action in the body.
5.Reducing toxic side effects: By increasing the drug concentration within cancer cells, Methyl-β-cyclodextrin can reduce the toxic side effects of drugs on normal cells, decreasing adverse reactions during treatment.
In summary, Methyl-β-cyclodextrin in cancer drug delivery can enhance drug solubility, stability, and targeting, thereby improving the therapeutic effect of drugs while mitigating toxic side effects. It offers new possibilities and strategies for cancer treatment. However, specific effects require further research and validation based on different drugs, types of cancer, and treatment regimens.
